RESEND: Metlifecare likely to see share price surge, says First NZ Capital

RESEND: Metlifecare likely to see share price surge, says First NZ Capital
Edwin Mitson
By Fiona Rotherham (RESEND clarifies target price of $5.90 in 7th par)  May 5 (BusinessDesk) - Analysts are picking a likely upsurge in the share price of retirement village operator Metlifecare in coming months due to a ramp-up in development, change in leadership, and supportive conditions, despite the company having traded at a discount relative to its industry peers over the past decade. Metlifecare delivered net profit of $125.7 million in the first half of 2016, more than three times higher than the previous year, mainly due to a li...